ArticleTrials2024

Protocol of a monocentric, double-blind, randomized, superiority, controlled trial evaluating the effect of in-prison OROS-methylphenidate vs. placebo treatment in detained people with attention-deficit hyperactivity disorder (BATIR).

Stéphanie Baggio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.